0591-0348
Generic: triamterene and hydrochlorothiazide
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
triamterene and hydrochlorothiazide
Labeler
actavis pharma, inc.
Dosage Form
TABLET
Active Ingredients
hydrochlorothiazide 50 mg/1, triamterene 75 mg/1
Identifiers & Regulatory
Product NDC
0591-0348
Product ID
0591-0348_3f660528-4c98-4c59-80b4-13c1cb817f8e
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Marketing Start
1993-09-23
Marketing End
2028-04-30
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05910348
Hyphenated Format
0591-0348
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
triamterene and hydrochlorothiazide (source: label)
Generic Name
triamterene and hydrochlorothiazide (source: ndc)
Application Number
ANDA071851 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 50 mg/1
- 75 mg/1
Packaging
- 24900 TABLET in 1 BAG (0591-0348-00)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "3f660528-4c98-4c59-80b4-13c1cb817f8e", "openfda": {}, "finished": false, "packaging": [{"description": "24900 TABLET in 1 BAG (0591-0348-00)", "package_ndc": "0591-0348-00", "marketing_end_date": "30-APR-28", "marketing_start_date": "23-SEP-93"}], "product_id": "0591-0348_3f660528-4c98-4c59-80b4-13c1cb817f8e", "dosage_form": "TABLET", "product_ndc": "0591-0348", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "50 mg/1"}, {"name": "TRIAMTERENE", "strength": "75 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_end_date": "20280430", "marketing_start_date": "19930923"}